Innate Pharma S.A. (EPA:IPH)
France · Delayed Price · Currency is EUR 1.540
+0.016 (1.05%)
Jan 12, 2026, 11:41 AM CET
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €140.48 million as of January 12, 2026. Its market cap has decreased by -12.17% in one year.
Market Cap
140.48M
Enterprise Value
107.48M
Revenue
12.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.54
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 140.48M, an increase of 17,634.83%. That is a compound annual growth rate of 30.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 140.48M | -4.87% |
| Dec 31, 2025 | 147.67M | -7.67% |
| Dec 31, 2024 | 159.94M | -24.29% |
| Dec 29, 2023 | 211.24M | -19.93% |
| Dec 30, 2022 | 263.84M | -24.98% |
| Dec 31, 2021 | 351.67M | 28.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 128.15B |
| Sanofi | 102.75B |
| Sartorius Stedim Biotech | 20.85B |
| bioMérieux | 13.33B |
| Eurofins Scientific SE | 12.24B |
| Ipsen | 10.46B |
| ABIVAX Société Anonyme | 7.71B |
| Virbac | 3.05B |